Variant report

Variant	nsv877109
Chromosome Location	chr3:85892098-86006210
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr3:85979706..85982115-chr3:85984634..85986729,2	K562	blood:
2	chr3:85963263..85965350-chr3:85981290..85983775,2	MCF-7	breast:
3	chr3:85979706..85982115-chr3:85984634..85986729,2	K562	blood:
4	chr3:85963263..85965350-chr3:85981290..85983775,2	MCF-7	breast:

Extended variants
information (count: 2787 )
Associated
traits (count: 77 )

Variant overlapped rSNPs/rCNVs (count:2787 , 50 per page) page: 1 2 3 4 5 6 7 ... 56

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs538124138	chr3:85896000-85896001	Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs376841829	chr3:85896016-85896017	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs555776609	chr3:85896039-85896040	Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs574061395	chr3:85896041-85896042	Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs150299782	chr3:85896075-85896076	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs553405124	chr3:85896095-85896096	Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs572608847	chr3:85896175-85896176	Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs137858418	chr3:85896180-85896181	Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs72908602	chr3:85896213-85896214	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs540685668	chr3:85896255-85896256	Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs531937354	chr3:85896264-85896265	Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs544076476	chr3:85896279-85896280	Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs536965198	chr3:85896280-85896281	Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs558784325	chr3:85896281-85896282	Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs576790579	chr3:85896283-85896284	Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs562078837	chr3:85896286-85896287	Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs529273548	chr3:85896361-85896362	Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs547923928	chr3:85896371-85896372	Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs559930152	chr3:85896384-85896385	Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs533466031	chr3:85896403-85896404	Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs552117901	chr3:85896499-85896500	Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs554417415	chr3:85896500-85896501	Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs570612067	chr3:85896531-85896532	Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs143418009	chr3:85896548-85896549	Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs147230136	chr3:85896583-85896584	Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs74433724	chr3:85896590-85896591	Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs544942153	chr3:85899815-85899816	Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs563296704	chr3:85899835-85899836	Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs375484429	chr3:85899847-85899848	Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs148851568	chr3:85899859-85899860	Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs561006043	chr3:85899910-85899911	Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs188281702	chr3:85899944-85899945	Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs527770538	chr3:85899994-85899995	Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs193051776	chr3:85900013-85900014	Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs183937408	chr3:85900095-85900096	Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs116450426	chr3:85900125-85900126	Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs550962999	chr3:85900168-85900169	Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs568913073	chr3:85900239-85900240	Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs536202022	chr3:85900261-85900262	Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs73847404	chr3:85900270-85900271	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs111573174	chr3:85900303-85900304	Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs187565788	chr3:85900332-85900333	Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs116146257	chr3:85900357-85900358	Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs534022618	chr3:85900418-85900419	Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs531055594	chr3:85900480-85900481	Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs79188667	chr3:85900528-85900529	Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs577736784	chr3:85900599-85900600	Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs532548395	chr3:85900819-85900820	Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs188707194	chr3:85900861-85900862	Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs533366218	chr3:85900875-85900876	Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:77)

Disease	PMID	Source
Glioblastoma multiforme	21080181	CNVD
Melanoma	18172304	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Insulin resistance	16721378	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Ewing''s sarcoma	21437220	CNVD
Neuroblastoma	21484798	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Oral cancer	19627613	CNVD
Renal cell carcinoma	19461508	CNVD
Epithelial cancer	22065749	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Acute myeloid leukemia	16864856	CNVD
Liposarcoma	21253554	CNVD
Basal cell lymphoma	21115979	CNVD
Endometrial cancer	22040021	CNVD
Pancreatic endocrine tumor	20981439	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	17387387	CNVD
Oral cancer	21386901	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Acute myeloid leukemia	20729466	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Retinoblastoma	21504564	CNVD
Renal cell carcinoma	21668985	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	17603634	CNVD
Esophageal cancer	20955586	CNVD
Uveal melanoma	20484589	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Hirschsprung''s Disease	21712996	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cancer	21183584	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Bipolar disorder	20877625	CNVD
Bipolar disorder	21956041	CNVD
Bipolar disorder	22241247	CNVD
Biliary cancer	18923514	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Prostate cancer	21965145	CNVD
Cancer	21129771	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Cervical cancer	21062161	CNVD
Squamous cell cancer	20885788	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Cancer	20164919	CNVD
Metanephric adenoma	20802469	CNVD
Bipolar disorder	18458673	CNVD
Breast cancer	22032731	CNVD
Wilms tumour	21544195	CNVD
Colorectal cancer	16272173	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Soft tissue tumor	16732325	CNVD
small cell lung cancer	20016488	CNVD
Neurodevelopmental disorder	22521361	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Mental retardation	17124404	CNVD
Esophageal squamous carcinoma	17470683	CNVD
Myelofibrosis	22110671	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
craniofacial dysmorphism	21918468	CNVD
Prostate cancer	21307934	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:165 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:85896000-85896600	Enhancers	Hela-S3	cervix
2	chr3:85899800-85900200	Enhancers	Fetal Kidney	kidney
3	chr3:85900000-85900200	Enhancers	HUES48 Cell Line	embryonic stem cell
4	chr3:85900200-85900600	Enhancers	iPS-15b Cell Line	embryonic stem cell
5	chr3:85900800-85901000	Enhancers	HUES48 Cell Line	embryonic stem cell
6	chr3:85906600-85907000	Enhancers	Brain Substantia Nigra	brain
7	chr3:85910000-85910200	Enhancers	Spleen	Spleen
8	chr3:85910600-85912600	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
9	chr3:85912000-85912400	Enhancers	HUES48 Cell Line	embryonic stem cell
10	chr3:85912200-85912800	Enhancers	Fetal Heart	heart
11	chr3:85912200-85914400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
12	chr3:85912600-85913800	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
13	chr3:85913000-85913600	Enhancers	Brain Anterior Caudate	brain
14	chr3:85913600-85914400	Enhancers	Fetal Stomach	stomach
15	chr3:85914200-85914400	Enhancers	HUES48 Cell Line	embryonic stem cell
16	chr3:85914200-85914800	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
17	chr3:85914400-85914600	Enhancers	Fetal Heart	heart
18	chr3:85931000-85931600	Enhancers	iPS-18 Cell Line	embryonic stem cell
19	chr3:85931400-85931800	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
20	chr3:85931400-85931800	Enhancers	HUES6 Cell Line	embryonic stem cell
21	chr3:85933000-85936000	Weak transcription	Brain Inferior Temporal Lobe	brain
22	chr3:85935400-85939200	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
23	chr3:85936000-85936600	Enhancers	Fetal Heart	heart
24	chr3:85936400-85937600	Enhancers	Fetal Kidney	kidney
25	chr3:85936800-85938000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
26	chr3:85937800-85938000	Enhancers	Muscle Satellite Cultured Cells	--
27	chr3:85937800-85940000	Enhancers	HUES48 Cell Line	embryonic stem cell
28	chr3:85937800-85940400	Enhancers	iPS-15b Cell Line	embryonic stem cell
29	chr3:85938000-85939400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
30	chr3:85938200-85939000	Enhancers	iPS-18 Cell Line	embryonic stem cell
31	chr3:85938400-85940000	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
32	chr3:85938400-85940200	Enhancers	HUES64 Cell Line	embryonic stem cell
33	chr3:85938400-85940600	Enhancers	H1 Cell Line	embryonic stem cell
34	chr3:85938600-85939000	Enhancers	iPS-20b Cell Line	embryonic stem cell
35	chr3:85938600-85939600	Enhancers	HUES6 Cell Line	embryonic stem cell
36	chr3:85939000-85939400	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
37	chr3:85939000-85939600	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
38	chr3:85939000-85939600	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
39	chr3:85939000-85939800	Enhancers	ES-I3 Cell Line	embryonic stem cell
40	chr3:85939400-85940200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
41	chr3:85939600-85940200	Enhancers	iPS-20b Cell Line	embryonic stem cell
42	chr3:85939600-85940600	Enhancers	iPS-18 Cell Line	embryonic stem cell
43	chr3:85940000-85949000	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
44	chr3:85940200-85942000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
45	chr3:85942000-85942200	ZNF genes & repeats	ES-UCSF4 Cell Line	embryonic stem cell
46	chr3:85942200-85942800	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
47	chr3:85944200-85944600	ZNF genes & repeats	Ganglion Eminence derived primary cultured neurospheres	brain
48	chr3:85946800-85952200	Weak transcription	HUES64 Cell Line	embryonic stem cell
49	chr3:85949000-85949200	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
50	chr3:85952200-85953400	Enhancers	HUES64 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links